Thursday, December 18, 2008 10:31:06 PM
<<About IDM Pharma: The Company believes it has adequate cash resources to support its operations into the first half of 2009 based on its current development and operating plans. The Company does not currently have operational sales and marketing infrastructure for L-MTP-PE and does not currently have plans or sufficient funds to secure this capability. The Company continues to evaluate strategic alternatives, which may include seeking strategic partners, a merger and/or the sale of all or part of its operations and assets, or raising additional capital to secure operational sales and marketing infrastructure for L-MTP-PE.>>
At least the cancer patients can use L-MTP-PE in their struggle to survive. This is huge. I know two people who have died from cancer this year, one 21 years old and the other about 50. Horrible.
I am praying for >$8.50 a share in buy-out, but based on current IDM share price and the massive financial deleveraging we are witnessing in 2008 and into 2009, it could be between $5.50 to $7.50. JMHO.
At about 28M shares outstanding (high end) 28M x $8.50=$238M market cap.
Maybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing Agreement • AHRO • Aug 8, 2024 7:00 AM
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results • SNWV • Aug 8, 2024 6:59 AM
Kona Gold Beverage Inc. Signs Letter of Intent with Bemax, Inc. to Sell Kona Gold, LLC • BMXC • Aug 7, 2024 10:00 AM
Btab Ecommerce Group, Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • BBTT • Aug 7, 2024 9:00 AM
Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update • HYDI • Aug 7, 2024 8:52 AM
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM